Unresolved issues in combination chemotherapy.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D002330:Carmustine / Q000008:administration & dosage; D002453:Cell Cycle; D003520:Cyclophosphamide / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D004357:Drug Synergism; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008657:Metabolic Clearance Rate; D008727:Methotrexate / Q000008:administration & dosage; D009368:Neoplasm Transplantation
D003606:Dacarbazine; D003520:Cyclophosphamide; D001215:Asparaginase; D005472:Fluorouracil; D002330:Carmustine; D008727:Methotrexate